Mwale P, Hsieh C, Yen T, Jan J, Taliyan R, Yang C
Mol Neurodegener. 2025; 20(1):7.
PMID: 39827337
PMC: 11742494.
DOI: 10.1186/s13024-025-00801-8.
Fan M, Tian J, Chen T, Zhang C, Liu X, Zhao Z
World J Diabetes. 2024; 15(10):2041-2057.
PMID: 39493568
PMC: 11525733.
DOI: 10.4239/wjd.v15.i10.2041.
Bessot A, Medeiros Savi F, Gunter J, Mendhi J, Amini S, Waugh D
Adv Healthc Mater. 2024; 14(2):e2401939.
PMID: 39444080
PMC: 11729988.
DOI: 10.1002/adhm.202401939.
Jia W, Ma L, Yu X, Wang F, Yang Q, Wang X
Natl Sci Rev. 2024; 11(6):nwae142.
PMID: 38966071
PMC: 11223582.
DOI: 10.1093/nsr/nwae142.
Zhu Y, Jiang D, Qiu Y, Liu X, Bian Y, Tian S
Bioact Mater. 2024; 39:59-73.
PMID: 38800720
PMC: 11127178.
DOI: 10.1016/j.bioactmat.2024.05.019.
Engraftment of adult hematopoietic stem and progenitor cells in a novel model of humanized mice.
Yu C, Maser R, Marches F, Banchereau J, Palucka K
iScience. 2024; 27(3):109238.
PMID: 38433905
PMC: 10904995.
DOI: 10.1016/j.isci.2024.109238.
Unlocking Translational Potential: Conditionally Reprogrammed Cells in Advancing Breast Cancer Research.
Daneshdoust D, Luo M, Li Z, Mo X, Alothman S, Kallakury B
Cells. 2023; 12(19).
PMID: 37830602
PMC: 10572051.
DOI: 10.3390/cells12192388.
Progress, implications, and challenges in using humanized immune system mice in CAR-T therapy-Application evaluation and improvement.
Yue H, Bai L
Animal Model Exp Med. 2023; 7(1):3-11.
PMID: 37823214
PMC: 10961865.
DOI: 10.1002/ame2.12353.
Progress in building clinically relevant patient-derived tumor xenograft models for cancer research.
Wang W, Li Y, Lin K, Wang X, Tu Y, Zhuo Z
Animal Model Exp Med. 2023; 6(5):381-398.
PMID: 37679891
PMC: 10614132.
DOI: 10.1002/ame2.12349.
Thymocyte Development of Humanized Mice Is Promoted by Interactions with Human-Derived Antigen Presenting Cells upon Immunization.
Fukuhara T, Ueda Y, Lee S, Odaka T, Nakajima S, Fujisawa J
Int J Mol Sci. 2023; 24(14).
PMID: 37511462
PMC: 10380196.
DOI: 10.3390/ijms241411705.
Review of the Immune Checkpoint Inhibitors in the Context of Cancer Treatment.
Alturki N
J Clin Med. 2023; 12(13).
PMID: 37445336
PMC: 10342855.
DOI: 10.3390/jcm12134301.
Conditional Reprogramming Modeling of Bladder Cancer for Clinical Translation.
Daneshdoust D, Yin M, Luo M, Sundi D, Dang Y, Lee C
Cells. 2023; 12(13).
PMID: 37443748
PMC: 10341071.
DOI: 10.3390/cells12131714.
Generation, evolution, interfering factors, applications, and challenges of patient-derived xenograft models in immunodeficient mice.
Zeng M, Ruan Z, Tang J, Liu M, Hu C, Fan P
Cancer Cell Int. 2023; 23(1):120.
PMID: 37344821
PMC: 10283277.
DOI: 10.1186/s12935-023-02953-3.
Preclinical models for development of immune-oncology therapies.
Wang Y, Shelton S, Kastrunes G, Barbie D, Freeman G, Marasco W
Immuno-oncol Insights. 2023; 3(8):379-398.
PMID: 37132013
PMC: 10150782.
DOI: 10.18609/ioi.2022.41.
The Chorioallantoic Membrane Xenograft Assay as a Reliable Model for Investigating the Biology of Breast Cancer.
Ranjan R, Muenzner J, Kunze P, Geppert C, Ruebner M, Huebner H
Cancers (Basel). 2023; 15(6).
PMID: 36980588
PMC: 10046776.
DOI: 10.3390/cancers15061704.
Evolution of 3D Cultures: Toward Tailored Preclinical Models.
Benelli R, Zocchi M, Poggi A
Cancers (Basel). 2023; 15(2).
PMID: 36672464
PMC: 9857187.
DOI: 10.3390/cancers15020515.
Short-term carcinogenicity study of N-methyl-N-nitrosourea in FVB-Trp53 heterozygous mice.
Kim N, Seo S, Yoo E, Kang A, Lee J, Lee J
PLoS One. 2023; 18(1):e0280214.
PMID: 36608059
PMC: 9821506.
DOI: 10.1371/journal.pone.0280214.
First-line Evaluation of Sperm Parameters in Mice ( ).
Martinez G
Bio Protoc. 2022; 12(20).
PMID: 36353714
PMC: 9606453.
DOI: 10.21769/BioProtoc.4529.
Insights into mechanisms of graft-versus-host disease through humanised mouse models.
Elhage A, Sligar C, Cuthbertson P, Watson D, Sluyter R
Biosci Rep. 2022; 42(9).
PMID: 35993192
PMC: 9446388.
DOI: 10.1042/BSR20211986.
Mouse Models of Hepatocellular Carcinoma: Classification, Advancement, and Application.
Liu S, Huang F, Ru G, Wang Y, Zhang B, Chen X
Front Oncol. 2022; 12:902820.
PMID: 35847898
PMC: 9279915.
DOI: 10.3389/fonc.2022.902820.